Kasus Covid-19 di Asean Tinggi, Menlu Retno Klaim Indonesia Sudah Membaik bisnis.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bisnis.com Daily Mail and Mail on Sunday newspapers.
Transgene Expands Phase II Clinical Trial of Therapeutic Vaccine TG4001 in Combination With Avelumab Versus Avelumab Monotherapy in Patients With HPV16-positive Anogenital Cancers
-
Trial will focus on patients without liver metastases, based on encouraging data in Phase Ib/II study
-
Trial targets indications where clinical outcomes can be improved versus standard therapeutic options and immune checkpoint inhibitors ( ICIs )
-
Continued clinical collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to conduct the expanded Phase II study
Regulatory News:
Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, today announces the expansion of a randomized, controlled study with TG4001 in combination with avelumab versus avelumab monotherapy in patients with HPV16-positive anogenital tumors (NCT: 03260023)